Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Laura Pierotti in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Cremolini in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Antonio Chella in
Google Scholar
PubMed
Search for other papers by Andrea Antonuzzo in
Google Scholar
PubMed
Search for other papers by Daniele Sgrò in
Google Scholar
PubMed
Search for other papers by Lucia Antonangeli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
). Reference ranges were 8–18 ng/dL for FT4, 2.5–5.0 ng/L for FT3 and 0.4–4 mIU/L for TSH. Tg was measured by an immunometric assay (Access Thyroglobulin assay; Beckman Coulter, Inc., Fullerton, CA, USA) (functional sensitivity 0.1 ng/mL). TgAbs were measured
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Search for other papers by Kenneth Ka Hei Lai in
Google Scholar
PubMed
Department of Ophthalmology, Salmaniya Medical Complex, Government Hospitals, Bahrain
Search for other papers by Fatema Mohamed Ali Abdulla Aljufairi in
Google Scholar
PubMed
Department of Ophthalmology, Vicente Sotto Memorial Medical Center, Cebu City, Philippines
Search for other papers by Jake Uy Sebastian in
Google Scholar
PubMed
Search for other papers by Yingying Wei in
Google Scholar
PubMed
Search for other papers by Ruofan Jia in
Google Scholar
PubMed
Search for other papers by Karen Kar Wun Chan in
Google Scholar
PubMed
Search for other papers by Elaine Yuen Ling Au in
Google Scholar
PubMed
Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Search for other papers by Chiu Ming Ng in
Google Scholar
PubMed
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Hunter Kwok Lai Yuen in
Google Scholar
PubMed
Search for other papers by Wilson Wai Kuen Yip in
Google Scholar
PubMed
Search for other papers by Alvin Lerrmann Young in
Google Scholar
PubMed
Search for other papers by George Pak Man Cheng in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Clement Chee Yung Tham in
Google Scholar
PubMed
Search for other papers by Chi Pui Pang in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Kelvin Kam Lung Chong in
Google Scholar
PubMed
.4 MRD1 (mm) 5.3 ± 1.7 EOMy 1.8 ± 1.0 Diplopia 0.7 ± 0.8 Exophthalmos (mm) 19 ± 3 Mild^ 88 Moderate to severe^ 157 DON 10 (4%) *Reference range of TSH = 0.27 to 4.20 mIU/L; **Reference range of
Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Maria Regina Calsolari in
Google Scholar
PubMed
thyroid hormone concentrations within the reference range [ 1 , 2 , 5 ]. In a recent editorial, Professor Wiersinga proposed to add the presence of thyroid disease for the diagnosis of SCH [ 5 ]. This new definition prevents the erroneous treatment of
Search for other papers by Genfeng Yu in
Google Scholar
PubMed
Search for other papers by Siyang Liu in
Google Scholar
PubMed
Search for other papers by Cheng Song in
Google Scholar
PubMed
Search for other papers by Qintao Ma in
Google Scholar
PubMed
Search for other papers by Xingying Chen in
Google Scholar
PubMed
Search for other papers by Yuqi Jiang in
Google Scholar
PubMed
Search for other papers by Hualin Duan in
Google Scholar
PubMed
Search for other papers by Yajun He in
Google Scholar
PubMed
Search for other papers by Dongmei Wang in
Google Scholar
PubMed
Search for other papers by Heng Wan in
Google Scholar
PubMed
Search for other papers by Jie Shen in
Google Scholar
PubMed
syndrome is defined as T3 levels below the lower limit of normal. However, we included in this study a population with FT3, FT4, and TSH, all within the reference range. Therefore, FT3/FT4 is superior to FT3 in a population with normal thyroid function
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Vincenzo Toscano in
Google Scholar
PubMed
Search for other papers by Dan Alexandru Niculescu in
Google Scholar
PubMed
Search for other papers by Diana Loreta Paun in
Google Scholar
PubMed
Search for other papers by Catalina Poiana in
Google Scholar
PubMed
of the normal reference range for a pregnant woman in the first trimester (TPOAb negative), whilst a quarter considered 4.0 mIU/L to be the upper limit of normal. The ATA suggestion to elevate the upper limit of TSH from 2.5 to 4.0 mIU/L is probably
Search for other papers by Camille Galy-Bernadoy in
Google Scholar
PubMed
Search for other papers by Benjamin Lallemant in
Google Scholar
PubMed
Search for other papers by Guillaume Chambon in
Google Scholar
PubMed
Search for other papers by Huy Trang Pham in
Google Scholar
PubMed
Search for other papers by Christophe Reynaud in
Google Scholar
PubMed
Search for other papers by Caroline Alovisetti in
Google Scholar
PubMed
Search for other papers by Quentin Bonduelle in
Google Scholar
PubMed
Search for other papers by Anne Marie Guedj in
Google Scholar
PubMed
Search for other papers by Serge Lumbroso in
Google Scholar
PubMed
Search for other papers by David-Paul De Brauwere in
Google Scholar
PubMed
variation, reference range, and functional sensitivity were respectively <2.6%, <5.8% (12–88 ng/L), and <4 ng/L. Elecsys 2010 Roche (Mannheim, Germany), whose intra-assay and inter-assay coefficient of variation, reference range, and functional
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Renata Alencar in
Google Scholar
PubMed
Search for other papers by Daniel Barretto Kendler in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Carla Nava in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Cencita Cordeiro de Noronha Pessoa in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
prognosis even within the “reference range.” In the present study, the cutoff for CA19-9 was much lower than the one traditionally used for pancreatic tumors, suggesting that maybe, for MTC, a specific “reference range” should be established. In fact, the
Search for other papers by Eyun Song in
Google Scholar
PubMed
Search for other papers by Jonghwa Ahn in
Google Scholar
PubMed
Search for other papers by Hye-Seon Oh in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
97.5th percentile of the serum TSH levels of the reference population, as previously reported [ 10 ]. Serum fT4 was also measured using electrochemiluminescence immunoassay (E-Free T4 kit, Roche Diagnostics, Mannheim, Germany), and the reference range
Search for other papers by Sujoy Ghosh in
Google Scholar
PubMed
Search for other papers by Subhodip Pramanik in
Google Scholar
PubMed
Search for other papers by Kaushik Biswas in
Google Scholar
PubMed
Search for other papers by Kingshuk Bhattacharjee in
Google Scholar
PubMed
Search for other papers by Rajib Sarkar in
Google Scholar
PubMed
Search for other papers by Subhankar Chowdhury in
Google Scholar
PubMed
Search for other papers by Pradip Mukhopadhyay in
Google Scholar
PubMed
25 subjects (M 8, F 17) with newly diagnosed hypothyroid (TSH >10 mU/L with FT4 below normal reference range) were included as “newly diagnosed hypothyroid group” (group B). The third group consisted of consecutive 25 follow-up subjects with
Search for other papers by Rajesh Rajput in
Google Scholar
PubMed
Search for other papers by Vaibhav Pathak in
Google Scholar
PubMed
and T4, with an increase in TSH with the weekly dose, but the mean TSH in both of our study groups remained within the reference range at all times. Pharmacogenomic studies have suggested that the polymorphism in genes for deiodinase enzyme may be